home / stock / hjli / hjli news

HJLI News and Press, Hancock Jaffe Laboratories Inc. From 09/16/19

Stock Information
Company Name: Hancock Jaffe Laboratories Inc.
Stock Symbol: HJLI
Market: NASDAQ
Menu
HJLI HJLI Quote HJLI Short HJLI News HJLI Articles HJLI Message Board
Get HJLI Alerts

News, Short Squeeze, Breakout and More Instantly...
HJLI - Hancock Jaffe Appoints Global Healthcare Executive Matthew Jenusaitis and Financial and Medical Reimbursement Expert Robert Gray to its Board of Directors

Experienced Medical Device and Reimbursement Executives Added to Board Ahead of Key Product Milestones and Pre-FDA Meetings IRVINE, CA / ACCESSWIRE / September 16, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore car...
HJLI - Hancock Jaffe Medical Advisory Board Member Dr. Steven Elias Presents at International Union of Phlebology Conference in Krakow, Poland

Presentation Featured VenoValve as Potential Treatment of Chronic Venous Disease IRVINE, CA / ACCESSWIRE / August 29, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that on August 25,...

HJLI - Hancock Jaffe to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019

IRVINE, CA / ACCESSWIRE / August 27, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) (NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, has been invited to present at the H.C. Wainwright 21 st Annual Global Investment Conference on September ...

HJLI - Hancock Jaffe Successfully Completes Two Additional VenoValve Implantations for First-in-Man Study

Eight Patients Now Part of First-in-Man Bogota Study IRVINE, CA / ACCESSWIRE / August 20, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, has successfully implanted VenoValves in two additional patien...
HJLI - Principle Investigator Dr. Jorge Hernando Ulloa Reports New 90 Day VenoValve Data at the Second Annual Society of Vascular and Endovascular Surgery Congress of Central America and the Caribbean

Reflux Now at Normal Levels in All Four VenoValve Patients IRVINE, CA / ACCESSWIRE / July 26, 2019 / Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that on Thu...

HJLI - Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present New 90 Day VenoValve Data at the Second Annual Society of Vascular and Endovascular Surgery Congress of Central America and the Caribbean On July 25, 2019

Management to Host VenoValve Webcast and Conference Call on July 25, 2019 at 11:00 am Eastern Time IRVINE, CA / ACCESSWIRE / July 19, 2019 / Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular hea...

HJLI - Hancock Jaffe Reports Early Positive Results For CoreoGraft Animal Feasibility Study

No Device Failures in Eight Test Subjects IRVINE, CA / ACCESSWIRE / June 27, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, today provided an update on the status of its CoreoGraft animal feasibi...
HJLI - Primary Investigator Dr. Jorge Hernando Ulloa Reports New and Updated VenoValve Data at C3 Global Conference

Clinical Manifestations of CVI Improved an Average of 46% Across All Five VenoValve Patients IRVINE, CA / ACCESSWIRE / June 24, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that on...

HJLI - Hancock Jaffe Hires Brian Roselauf as Director of Research and Development

IRVINE, CA / ACCESSWIRE / June 20, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, today announced that Brian Roselauf will be joining the company as its Director of Research and Development. Mr. Rosela...

HJLI - Hancock Jaffe Primary Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Report at the Venous Summit at the C3 Global Conference

VenoValve Presentation on June 23, 2019 in Orlando, Florida IRVINE, CA / ACCESSWIRE / June 19, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that Dr. Jorge Hernando Ulloa, HJLI's ...
Previous 10 Next 10